| Descriptor English: | Glycated Serum Albumin | ||||||
| Descriptor Spanish: |
Albúmina Sérica Glicada
| ||||||
| Descriptor Portuguese: | Albumina Sérica Glicada | ||||||
| Descriptor French: | Albumine sérique glycosylée | ||||||
| Entry term(s): |
Albumin, Glycated Serum Albumin, Glycosylated Serum Albumin, Serum Glycated Glycated Albumin, Serum Glycoalbumin Glycosyl Albumin Glycosyl-Albumin Glycosylated Serum Albumin Serum Albumin, Glycated Serum Albumin, Glycosylated Serum Glycated Albumin |
||||||
| Tree number(s): |
D09.400.205.625.500.500 D09.400.430.825.500.500 D12.776.034.841.113 D12.776.124.335.500 D12.776.124.727.188 D12.776.395.351.500.500 D23.946.381.625.500.500 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000093423 | ||||||
| Scope note: | Serum albumin that has undergone, in vivo, spontaneous, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Public MeSH Note: | 2023; GLYCATED SERUM ALBUMIN was indexed under SERUM ALBUMIN 1981-2022 and GLYCATION END PRODUCTS, ADVANCED 2021-2022 |
||||||
| History Note: | 2023 |
||||||
| DeCS ID: | 60178 | ||||||
| Unique ID: | D000093423 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2023/01/01 | ||||||
| Date of Entry: | 2022/07/08 | ||||||
| Revision Date: | 2022/04/06 |
-
-
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
Glycated Serum Albumin
- Preferred
| Concept UI |
M000754076 |
| Scope note | Serum albumin that has undergone, in vivo, spontaneous, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA. |
| Preferred term | Glycated Serum Albumin |
| Entry term(s) |
Albumin, Glycated Serum Albumin, Glycosylated Serum Albumin, Serum Glycated Glycated Albumin, Serum Glycoalbumin Glycosyl Albumin Glycosyl-Albumin Glycosylated Serum Albumin Serum Albumin, Glycated Serum Albumin, Glycosylated Serum Glycated Albumin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
